Bayer CropScience Ltd Stock Price Today (NSE: BAYERCROP)

Bayer CropScience Ltd

4209.4024.40 (0.58%)
Market Closed

Fundamental Score

...

Bayer CropScience Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Bayer CropScience Ltd share price today is 4209.40, down 0.58% on NSE/BSE as of 17 June 2026. Bayer CropScience Ltd (BAYERCROP) is a Large-cap company in the Pesticides & Agrochemicals sector with a market capitalisation of 20.76K (Cr). The 52-week high for BAYERCROP share price is 6511.00 and the 52-week low is 4273.00. At a P/E ratio of 34.10x, BAYERCROP is currently trading above its industry average P/E of 29.36x. The company has a Return on Equity (ROE) of 19.96% and a debt-to-equity ratio of 0.03.

Bayer CropScience Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
4832.80
Low
4209.40
Volume
18.9K
Change
-1.37%

Bayer CropScience Ltd share price chart: -1.37% return over the past month. 52-week high ₹6511.00, 52-week low ₹4273.00.

Bayer CropScience Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
4499.104509.904426.604465.8017.42K (Cr)
4510.904617.004476.004522.0017.70K (Cr)
4668.904670.004473.804509.5037.89K (Cr)
4605.004686.804581.604615.8080.96K (Cr)
4377.004530.004377.004500.8032.12K (Cr)
4410.004445.004315.304368.8013.51K (Cr)
4345.004408.104306.004382.5012.23K (Cr)
4341.504374.904309.004323.407.39K (Cr)
4355.004363.004300.004315.5017.97K (Cr)
4300.004371.004290.504354.2018.08K (Cr)

Bayer CropScience Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
4510.904617.004426.604465.80-1.00%
4787.904832.804279.104509.50-5.81%
4674.905063.004584.004764.10+1.91%
4601.804782.004323.004645.60+0.95%
4395.004966.804332.204672.40+6.31%
4558.004585.604273.004466.20-2.01%
4640.004673.904275.204558.00-1.77%
4884.604915.004431.004658.40-4.63%
4810.005149.904540.004884.60+1.55%
5294.505489.004792.004810.50-9.14%
6405.006429.005194.005231.50-18.32%
6270.006511.006135.006322.50+0.84%

AI Research Briefing

Powered by Gemini · 2026-04-10

Litigation overhang and valuation keep a lid on Bayer CropScience, despite strong sector tailwinds.

Research Confidence
6.0/10Moderate
COMPOUNDERBreakdown, 1M: -5.67%, 3M: -11.43%, 6M: -17.71%.Expensive, P/E of 34.1x vs Industry P/E of 29.36x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Bayer CropScience closed its trading window on April 1, 2026, in anticipation of the financial results for the quarter and year ending March 31, 2026. A block trade of was executed on NSE involving approximately 50,585 shares at , indicating institutional activity. The company also received an ESG rating of 67.1 from SES ESG Research.

CORE STORY (THE REAL GAME)

Bayer CropScience is a play on the increasing demand for crop protection and yield enhancement in India, driven by a growing population and the need for greater agricultural efficiency. However, potential liabilities from glyphosate litigation and global headwinds create uncertainty.

Why Now
  • Upcoming earnings release could provide clarity on financial performance
  • Block trade indicates institutional interest
  • ESG rating may attract further investment
Potential Catalysts
  • Positive earnings surprise
  • Favorable resolution of glyphosate litigation
  • Significant order wins
Key Risks
  • Glyphosate litigation risk
  • Expensive valuation relative to industry P/E
  • Global headwinds in seeds and crop protection
Institutional Activity

Recent block trade suggests some institutional interest, but DII holdings decreased slightly.

Macro Context

Agrochemical industry benefits from the need for increased food production, but faces pressure from environmental concerns and regulations.

Cash Flow Quality

Profit converting to cash, Free Cash Flow 5Y: ₹2494.6 Cr.

3–6 Month Outlook

Bayer CropScience's performance in the next 3-6 months will be determined by its ability to navigate litigation risks and capitalize on growth opportunities in the Indian agrochemical market. Focus on sustainable solutions will be key.

Primary Thesis Risk

Glyphosate litigation could wipe out years of profits.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Excellent

Return on Equity (ROE)

19.96%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

24.80%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

16.98%

Average operating profit margin over 5 years

Good

Dividend Yield

2.71%

Annual dividend as % of current share price

Bayer CropScience Ltd Valuation Check

Poor

Price to Earnings (P/E)

34.10x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

29.36x

Average P/E of all peers in this sector

Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.

Shareholding Pattern

Excellent

Promoter Holding

71.43%

% shares held by company founders/management

Poor

FII Holding

3.80%

% shares held by foreign institutional investors

Good

DII Holding

11.22%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

12.03%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-10.60%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

8.68%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-0.06%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-0.06%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.03x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

40.84x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

2.49K (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Bayer CropScience Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of BAYERCROP across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Strong Return on Equity (19.96%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (24.80%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (16.98%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Conservative Debt Levels (D/E: 0.03)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (40.84x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹2494.60 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (71.43%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Revenue Contraction (-10.60%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Weak Earnings Growth (-0.06% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-0.06% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Bayer CropScience Ltd vs Pesticides & Agrochemicals Peers

Peer Comparison - Pesticides & Agrochemicals

Compare Bayer CropScience Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
46/100
4209
₹20761.67
34.1
Average
19.96%
Good
24.80%
Excellent
0.0
Excellent
-0.06%
Poor
8.68%
Good
2.71%
UPL Ltd...
UPL512070
29.8/100
633
₹63303.75
26.7
Average
3.29%
Poor
7.66%
Poor
0.9
Good
-16.10%
Poor
5.46%
Good
0.80%
63.8/100
3125
₹51402.12
34.0
Average
17.61%
Good
22.86%
Excellent
0.0
Excellent
29.53%
Excellent
18.83%
Excellent
0.47%
51.9/100
469
₹23622.23
43.7
Average
18.81%
Good
25.14%
Excellent
0.0
Excellent
17.27%
Excellent
4.98%
Average
0.25%
68.3/100
916
₹7868.22
17.4
Average
12.62%
Average
16.50%
Good
0.0
Excellent
8.25%
Good
16.62%
Excellent
1.03%
56.7/100
1180
₹5600.99
20.0
Average
21.95%
Excellent
28.29%
Excellent
0.0
Excellent
15.69%
Excellent
12.69%
Good
0.16%
28.4/100
253
₹5133.00
30.1
Average
6.65%
Poor
10.12%
Average
0.0
Excellent
-6.88%
Poor
3.41%
Average
0.95%
32.4/100
1489
₹4344.48
31.3
Average
11.09%
Average
14.33%
Average
0.1
Excellent
-6.27%
Poor
-0.71%
Poor
0.01%
0/100
162
₹3826.07
-25.75%
Poor
-7.80%
Poor
1.1
Average
4.00%
Average
0.00%
31.2/100
245
₹3163.13
259.5
Average
2.53%
Poor
5.19%
Poor
0.3
Excellent
22.42%
Excellent
12.39%
Good
0.06%
45.9/100
759
₹2110.03
14.2
Average
13.53%
Average
17.43%
Good
0.2
Excellent
10.22%
Good
7.97%
Good
0.28%

Bayer CropScience Ltd PE Ratio History

Historical price-to-earnings ratio for BAYERCROP — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 2025126.38₹4558.0036.1x
FY 2024164.77₹5550.9533.7x
FY 2023168.71₹5551.8532.9x
FY 2022143.58₹4937.4034.4x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Bayer CropScience Ltd Dividend History

Annual cash dividends paid by BAYERCROP — dividend yield 2.71%

Financial YearDividends Paid (₹ Cr)
FY 2025560.80 Cr
FY 2024606.70 Cr
FY 2023561.10 Cr
FY 2022672.80 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Bayer CropScience Ltd Quarterly Performance

Latest quarterly metrics for BAYERCROP — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-10.60%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

12.03%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

8.68%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-0.06%

Compounded annual net profit growth over 5 years

Bayer CropScience Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for BAYERCROP — calculated from daily price history

49RSI 14
Neutral — RSI 49

Momentum is balanced — neither overbought nor oversold.

SMA 50
4610
▼ Price below SMA 50 — Short-term bearish
SMA 200
4771
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
18K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Bayer CropScience Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Bayer CropScience Ltd (BAYERCROP) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Bayer CropScience Ltd

About BAYERCROP (Bayer CropScience Ltd)

Bayer CropScience Ltd is a prominent force in the agricultural sector, dedicated to forging a sustainable future for farmers and the environment. As a global leader in crop protect...ion and innovative solutions, the company specializes in the research, development, and distribution of cutting-edge agrochemical products designed to safeguard crops from pests, diseases, and weeds. With a commitment to scientific advancement, Bayer CropScience empowers growers to maximize yields, enhance crop quality, and improve overall farm productivity. Beyond traditional chemical solutions, Bayer CropScience is at the forefront of developing biological crop protection products, incorporating digital farming technologies, and tailoring solutions to meet the specific needs of local environments. Through its comprehensive portfolio and unwavering dedication to innovation, Bayer CropScience is shaping the future of agriculture. The core business of Bayer CropScience revolves around a comprehensive suite of products encompassing insecticides, herbicides, fungicides, and seed treatments. These products are meticulously formulated to address the diverse challenges faced by farmers worldwide, whether it be controlling destructive insect populations, managing invasive weeds, or preventing the spread of fungal diseases. Bayer CropScience invests heavily in research and development to create highly effective and environmentally responsible products that minimize the impact on beneficial organisms and the broader ecosystem. Their portfolio includes innovative formulations, advanced delivery systems, and integrated pest management strategies, demonstrating their commitment to both crop protection and environmental stewardship. Their solutions are designed to optimize crop health and productivity while minimizing environmental impact. Beyond its core product offerings, Bayer CropScience is actively involved in developing advanced hybrid seeds optimized for specific growing conditions and regions. These seeds are bred to exhibit enhanced traits such as increased yield potential, disease resistance, and improved drought tolerance. In addition, the company actively engages in initiatives that promote sustainable agricultural practices, supporting farmer education and training programs to empower growers to adopt best management practices that conserve resources, protect biodiversity, and promote soil health. By fostering strong partnerships with farmers, researchers, and other stakeholders, Bayer CropScience strives to contribute to a more resilient and sustainable food production system that benefits both people and the planet.

Company Details

Symbol:BAYERCROP
Industry:Pesticides & Agrochemicals
Sector:Pesticides & Agrochemicals

Key Leadership

Mr. Simon-Thorsten Wiebusch
Vice Chairman, MD & CEO
Mr. Vinit Rajesh Jindal
Whole-Time Executive Director & CFO
Ms. Bharati Ratan Shetty
Company Secretary & Compliance Officer

BAYERCROP Share Price: Frequently Asked Questions

What is the current share price of Bayer CropScience Ltd?

Bayer CropScience Ltd (BAYERCROP) trades at ₹4209.40 on NSE and BSE. Market cap ₹20.76K (Cr). Educational data only.

What is the P/E ratio of Bayer CropScience Ltd?

Bayer CropScience Ltd has a P/E of 34.10x vs industry average 29.36x.

What is the Bull Run score for Bayer CropScience Ltd?

Bayer CropScience Ltd has a Bull Run score of 46/100 based on 25+ financial parameters.

Does Bayer CropScience Ltd pay dividends?

Bayer CropScience Ltd has a dividend yield of 2.71%. Past dividends don't guarantee future payments.

What is the ROE of Bayer CropScience Ltd?

Bayer CropScience Ltd has ROE of 19.96%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Bayer CropScience Ltd?

Bayer CropScience Ltd has debt-to-equity of 0.03.

Is Bayer CropScience Ltd a good investment?

Bull Run gives Bayer CropScience Ltd a score of 46/100. This is not investment advice — consult a SEBI-registered advisor.